Markets
Sartorius Stedim Biotech Posts Q1 Profit Growth, Reaffirms FY26 Outlook
Sartorius Stedim Biotech reported a rise in Q1 profit and revenue, driven by its consumables business, and confirmed its fiscal 2026 financial...
#biotechnology 11 articles
Stocks
Enveric Biosciences Secures Up to $13.9 Million in Private Placement
Enveric Biosciences announced a private placement expected to raise up to $13.9 million, with $5 million upfront and potential additional proceeds from...